Saudi Food and Drug Authority (SFDA) has temporarily suspended imports from Gulf Pharmaceutical Industries (Julphar) due to non-compliance with manufacturing regulations, according to the FDA Twitter account.
This decision came after several violations were detected in an FDA inspection.
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}